Migdal Insurance & Financial Holdings’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Sell |
770,909
-15,563
| -2% | -$213K | 0.13% | 84 |
|
|
2025
Q1 | $8.7M | Buy |
786,472
+100,000
| +15% | +$1.11M | 0.12% | 91 |
|
|
2024
Q4 | $7.31M | Hold |
686,472
| – | – | 0.1% | 87 |
|
|
2024
Q3 | $8.72M | Hold |
686,472
| – | – | 0.14% | 72 |
|
|
2024
Q2 | $11.5M | Hold |
686,472
| – | – | 0.19% | 74 |
|
|
2024
Q1 | $10.3M | Buy |
686,472
+38,170
| +6% | +$573K | 0.16% | 78 |
|
|
2023
Q4 | $9.73M | Hold |
648,302
| – | – | 0.2% | 76 |
|
|
2023
Q3 | $9.08M | Sell |
648,302
-50,000
| -7% | -$701K | 0.19% | 74 |
|
|
2023
Q2 | $7.23M | Hold |
698,302
| – | – | 0.17% | 77 |
|
|
2023
Q1 | $6.45M | Hold |
698,302
| – | – | 0.14% | 74 |
|
|
2022
Q4 | $6.19M | Hold |
698,302
| – | – | 0.14% | 72 |
|
|
2022
Q3 | $5.81M | Hold |
698,302
| – | – | 0.13% | 79 |
|
|
2022
Q2 | $5.72M | Hold |
698,302
| – | – | 0.13% | 76 |
|
|
2022
Q1 | $6.08M | Hold |
698,302
| – | – | 0.11% | 93 |
|
|
2021
Q4 | $6.64M | Hold |
698,302
| – | – | 0.06% | 123 |
|
|
2021
Q3 | $11.7M | Hold |
698,302
| – | – | 0.12% | 110 |
|
|
2021
Q2 | $10.7M | Hold |
698,302
| – | – | 0.11% | 118 |
|
|
2021
Q1 | $13.6M | Sell |
698,302
-40,000
| -5% | -$779K | 0.14% | 122 |
|
|
2020
Q4 | $13.3M | Hold |
738,302
| – | – | 0.16% | 97 |
|
|
2020
Q3 | $14.2M | Hold |
738,302
| – | – | 0.2% | 100 |
|
|
2020
Q2 | $19.3M | Hold |
738,302
| – | – | 0.31% | 71 |
|
|
2020
Q1 | $13.2M | Hold |
738,302
| – | – | 0.31% | 67 |
|
|
2019
Q4 | $24.6M | Sell |
738,302
-35,000
| -5% | -$1.17M | 0.47% | 49 |
|
|
2019
Q3 | $18.4M | Buy |
773,302
+420,000
| +119% | +$10M | 0.38% | 63 |
|
|
2019
Q2 | $12.7M | Hold |
353,302
| – | – | 0.32% | 64 |
|
|
2019
Q1 | $13.1M | Buy |
+353,302
| New | +$13.1M | 0.31% | 63 |
|